Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients wit...
Q2 2026
Aug 3, 2026
Q1 2026
Apr 30, 2026
FY 2025
Feb 19, 2026
Q4 2025
Q3 2025
Oct 30, 2025